If you have ever squinted at a medical bill wondering how a single blood test turned into four line items and a "patient responsibility" figure that felt invented, you have brushed up against the work of a company you have almost certainly never heard of. Waystar does not treat patients, sell insurance, or run a hospital. It runs the plumbing in between - the software that decides whether a claim gets paid, how fast, and how much of the bill lands back on you. Roughly half of all patients in the United States pass through those pipes.
That is an odd kind of fame: enormous reach, almost no name recognition. Waystar is a Louisville, Kentucky company that builds cloud software for what the industry calls the "revenue cycle" - the sprawling, deeply unglamorous process of getting a healthcare provider paid for care. In June 2024 it walked onto the Nasdaq under the ticker WAY, raised about $968 million, and stepped into public view at a valuation near $3.7 billion. For a business whose whole job is to be invisible, it was a loud debut.
01 — What it actually doesGetting paid is the hard part
In American healthcare, the gap between delivering care and collecting money for it is a canyon. A single claim can bounce between a provider, one or more insurers, and the patient, picking up errors, denials, and delays at every step. Waystar's pitch is to compress that canyon into one platform. Its software checks whether a patient is covered before the visit, automates prior authorizations, submits and monitors claims across thousands of payers, catches errors before a payer can reject them, fights denials when they happen, and collects the patient's share afterward.
The company organizes all of this into a handful of jobs: financial clearance (eligibility, prior auth, patient estimates), revenue capture, claim management, payment management, and denial prevention and recovery. Different names, one goal - money in, with fewer humans doing repetitive work along the way.
02 — Who uses itHospitals, practices, and everyone in between
Waystar's customers are the providers, not the patients. More than a million of them use the platform, from over 1,000 hospitals and health systems down to independent physician groups and multi-specialty practices. The through-line is that every one of them has a billing operation, and every billing operation loses money to friction. Big enterprise health systems want deep custom edits and scale; smaller practices want something that works out of the box. Waystar sells to both ends of that spectrum, which is part of why its reach is so wide.
03 — The problem it attacks450 million denied claims a year
The clearest way to understand Waystar is to look at what goes wrong without software like it. Claim denials are a chronic, expensive plague on American healthcare - hundreds of millions of claims get denied every year, and a large share are denials that could have been prevented or successfully appealed. When a hospital gives up on a denied claim, that is simply revenue leaking out the bottom. Waystar frames the opportunity in blunt terms: billions of dollars of administrative waste, and hundreds of millions of denials, sitting there waiting to be recovered.
That is why its 2025 product push centers on denials. The company talks about an "autonomous revenue cycle" - the idea that a growing slice of this repetitive back-office work can be handled by software rather than by overworked billing staff clicking through payer portals one claim at a time.
04 — The AI betAltitudeAI, the boring-AI in production
In 2025 Waystar rolled out AltitudeAI, a suite of AI and generative-AI features built on the company's own data network. It is a useful example of what "AI at work" looks like when it is not a chatbot. AltitudeCreate uses generative AI to draft content like denial appeal letters automatically. AltitudeAssist is an AI assistant that automates revenue cycle workflows so staff can get more done. AltitudePredict forecasts outcomes - which claims are likely to be denied, where payments will land - so teams can act before problems compound.
The advantage Waystar leans on is data. Its network processes more than six billion transactions a year across a million-plus providers, which is exactly the kind of proprietary corpus that makes predictions about payer behavior possible. The company has also partnered with Google Cloud to advance this work.
05 — How it got hereA merger, private equity, and a Nasdaq bell
Waystar is younger than its scale suggests. It was formed in 2017 when two rival billing companies - Navicure, a cloud clearinghouse founded in Georgia in 2001, and ZirMed, a Louisville analytics company founded in 1999 - merged, backed by Bain Capital. The combined company took the Waystar name in 2018. In 2019, private equity firm EQT and Canada's pension investor CPPIB took a majority stake at a valuation around $2.7 billion, and the company kept growing by acquisition, including buying eSolutions in 2020.
The growth curve is the part investors noticed. From roughly $60 million in revenue at the time of the merger, the combined business scaled past $600 million, reported $791 million in 2023, and guided to between $1.0 and $1.16 billion for 2025. That trajectory is what carried it to the public markets.
06 — The competitionCrowded, but the plumbing is sticky
Waystar is not alone in the revenue cycle. It competes with Change Healthcare (now part of Optum), Availity, R1 RCM, athenahealth, and FinThrive, among others. Each occupies a slightly different corner: R1 RCM tends to take on large hospital outsourcing; Availity's portal caters to providers registering directly with payers; FinThrive competes hard in the mid-market; Optum leans on the sheer scale of UnitedHealth Group. Waystar positions itself as an enterprise-grade, end-to-end platform that also serves smaller practices.
Its edge is less any single feature than the combination of breadth, the size of its data network, and how deeply the software embeds into a provider's daily operations. Software that sits at the center of how an organization gets paid is difficult and risky to rip out. That switching cost is the quiet moat under the whole business.
07 — The business modelRecurring revenue, growing with volume
Underneath it all, Waystar is a B2B software company. It sells subscription and transaction-based access to its platform, so revenue is largely recurring and grows as customers process more claims and payments, adopt more modules, and add AI capabilities on top. That is a durable shape: the more embedded the platform becomes, the more transactions flow through it, and the more each customer is worth over time. It is the opposite of a flashy consumer story, and that is rather the point.
08 — Where it fitsThe invisible layer of health-fintech
Zoom out and Waystar sits at an intersection most people never think about: healthcare, software, and payments. It is health tech, but it is also, functionally, fintech - moving money between patients, providers and payers and trying to make that movement accurate and fast. Its leadership, led by CEO Matt Hawkins since the 2017 founding, has pushed the company toward AI as the next lever, and the recognition has followed: a spot on the TIME100 Most Influential Companies list, a TIME Impact in AI Award, Forbes' Most Trusted Companies in America, and Healthcare Company of the Year at the 2025 Stevie Awards.
For patients, the ambition is subtle but real: clearer estimates, simpler bills, and fewer of those "why am I being charged this?" moments. For providers, it is money that would otherwise leak away. And for anyone studying how durable software businesses get built, Waystar is a clean case study in owning an unglamorous, essential layer - and letting AI compound the value on top of it.